Advertisement

Mycoplasmas stimulate mouse peritoneal macrophages to secrete lysosomal enzymes and to be cytotoxic

  • H. U. Schorlemmer
  • M. Kist
  • W. Bredit
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)

Abstract

The pathogenic mechanisms in mycoplasma infections are not fully understood. Several mechanisms may contribute to the recovery of animals from mycoplasma infections and resistance to reinfections. A feature of mycoplasma infections in the lungs and other sites is the associated mononuclear cell reaction. The infiltrating cells belong mainly to the lymphocyte and macrophage series. In bronchiolar exudates of mice infected with M.pulmonis 1,2 and hamsters infected with M.pneumoniae, macrophages are common. Serum antibodies transferred from mice recovering from pneumonia to recipient mice provides some protection against the development of pneumonia in these animals following inoculation of M.pulmonis 3. According to the well-known view of Mackaness4, immunity to infectious bacteria has two components.

Keywords

Migration Inhibitory Factor Lysosomal Enzyme Acid Hydrolase Macrophage Culture Mycoplasma Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lindsey, J. R. and Cassell, G. (1973). Experimental mycoplasma pulmonis infection in pathogen-free mice: models for studying mycoplasmosis of the respiratory tract. Am. J. Pathol., 72, 63PubMedGoogle Scholar
  2. 2.
    Taylor, G. and Taylor-Robinson, D. (1975). The part played by cell mediated immunity in mycoplasma respiratory infections. Dev. Biol. Stand., 28, 195PubMedGoogle Scholar
  3. 3.
    Taylor, G. and Taylor-Robinson, D. (1977). Factors involved in resistance to and recovery from mycoplasma pulmonis induced arthritis in mice. Ann. Rheum. Dis., 36, 232PubMedCrossRefGoogle Scholar
  4. 4.
    Mackaness, G. B. (1962). Cellular resistance to infection. J. Exp. Med., 116, 381PubMedCrossRefGoogle Scholar
  5. 5.
    Ward, P. A., Renold, H.G. and David, J. R. (1970). The production by antigen stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell. Immunol., 1,162PubMedCrossRefGoogle Scholar
  6. 6.
    Showell, H. S., Tear, R. J., Zigmond, S. H., Schiffman, G., Aswanikumar, S. Corcoran, B. and Becker, G. L. (1976). The structure-activity relations of synthetic peptides as chemotac-tic factors and inducers of lysosomal enzyme secretion for neutrophils. J. Exp. Med., 143, 1154PubMedCrossRefGoogle Scholar
  7. 7.
    Schoriemmer, H. U., Davies, P. and Allison, A. C. (1976). Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (London), 261, 48CrossRefGoogle Scholar
  8. 8.
    Ferluga, J., Schoriemmer, H. U., Baptisda, L. and Allison, A. C. (1976). Cytolytic effects of the complement cleavage product C3a. Br. J. Cancer, 34, 626PubMedCrossRefGoogle Scholar
  9. 9.
    Schoriemmer, H. U., Ferluga, J. and Allison, A. C. (1977). Interactions of macrophages and complement components in the pathogenesis of chronic inflammation. In Wil-loughby, D. A., Giroud, J. P. and Velo, G. P. (eds.) Perspectives in Inflammation, p. 191. (Lancaster: MTP Press)Google Scholar
  10. 10.
    Taylor-Robinson, D., Schoriemmer, H. U., Furr, P. M. and Allison, A. C. (1978). Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and immunity to these organisms. Clin. Exp. Immunol., 33, 486PubMedGoogle Scholar
  11. 11.
    Schoriemmer, H. U., Bitter-Suermann, D. and Allison, A.C. (1977) Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology., 32, 929Google Scholar
  12. 12.
    Mackaness, G. B. (1971). Resistance to intracellular infection. J. Infect. Dis., 123, 439PubMedCrossRefGoogle Scholar
  13. 13.
    Lai A Fat, R. F. M. and van Fürth, F. (1975). In vitro synthesis of some complement components (Clq, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology., 28, 359PubMedGoogle Scholar
  14. 14.
    Bentley, C., Bitter-Suermann, D., Hadding, U. and Brade, V. (1976). In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur. J. Immunol., 6, 393PubMedCrossRefGoogle Scholar
  15. 15.
    Schoriemmer, H. U., Hadding, U. and Bitter-Suemann, D. (1979). Effects of complement cleavage products released from stimulated macrophages in allergic diseases. Eur. J. Rheum. Inflam., 2, 130Google Scholar
  16. 16.
    Bredt, W. (1975). Phagocytosis by macrophages of mycoplasma pneumoniae after opsonization by complement. Infect. Immun., 12, 695Google Scholar
  17. 17.
    Bredt, W. and Bitter-Suermann, D. (1975). Interactions between mycoplasma pneumoniae and guinea pig complement. Infect. Immun., 11, 497PubMedGoogle Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • H. U. Schorlemmer
    • 1
  • M. Kist
    • 1
  • W. Bredit
    • 1
  1. 1.West Germany

Personalised recommendations